Nonprofit hospitals receive substantial tax breaks worth tens of billions each year. But how many hospitals actually give back to communities as much as they receive in tax benefits?
More
Hospitals have recently come under the spotlight for high prices and inadequate community benefit spending-- and now state policymakers are taking action. Here's an update on what's going on in the state hospital policy space.
More
A recent report revealed a plurality of hospital board members come from the Financial sector. How does this impact hospital community benefit spending and social responsibility?
More
A Pennsylvania appellate court recently denied property tax exemptions to four nonprofit hospitals because they were operating more like for-profits. Could other hospitals be next?
More
Insulin manufacturer Eli Lilly announced that it would be cutting the list price of its generic insulin products significantly. This move comes after decades of advocacy work by patients and clinicians alike, including our sister organization the Right Care Alliance. What does this tell us about the drug pricing landscape?
More
Earlier this month, Lown experts Dr. Vikas Saini and Judith Garber were featured on the Relentless Health Value podcast to talk about financial assistance, fair share spending, and why America needs a socially responsible healthcare system.
More
An investigation from Kaiser Health News shows that a large proportion of hospitals engage in aggressive practices to recoup medical debt. Is your hospital one of them?
More
Hospitals are starting to be held accountable for their community benefit spending -- how are they responding? We explore some cases in recent news.
More
Can hospitals advance patient safety in a profit-driven system? A recent study identifies persistent rates of adverse events in hospitals.
More
Hospitals are facing persistent staffing issues and many are in poor financial shape....but their CEOs keep getting bonuses. Could pay equity be the solution that stabilizes our hospitals?
More
An investigation of one Alzheimer's Disease drug and the approval of another offer lessons on accountability and evidence for new drug approvals.
More
"If we're ever going to get to the great health system that Americans deserve, we have to call out bad behavior," Vikas Saini, MD, president of the Lown Institute, said. "The Shkreli Awards are a mirror that's hard to look into, but we've got to do it."
More